Supplement Scholar
Amino Acid

ALCAR + ALA (Mitochondrial Protection)

Buy on Amazon ↗

Affiliate link: we may earn a commission at no extra cost to you. Disclosures

ALCAR + ALA (Mitochondrial Protection). Mitochondrial antioxidant stack — popularized as harm-reduction adjunct for MDMA neuroprotection.

How it works. ALCAR supports mitochondrial β-oxidation; ALA is a universal antioxidant and recycles vit C/E and glutathione.

What the research supports. 1 graded claims. Strongest: Animal evidence for reduced serotonergic neurotoxicity from MDMA (limited).

How much to take. Typical dose: ALCAR 500–1000 mg + ALA 300–600 mg before and 4–6h after; avoid late-night ALCAR.

Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.

Stacking. Pairs well with NAD+ precursor (NMN or NR), Omega-3.

Common forms. Available as Free-form crystalline powder, Capsules or tablets, Pre-mixed recovery or hydration beverages, Time-release formulations.

Key studies. 8 studies cited. The strongest are listed with links to PubMed.

Community. Experiences from people who have tried ALCAR + ALA (Mitochondrial Protection). Anecdotes are not medical advice.

ALCAR + ALA (Mitochondrial Protection). Mitochondrial antioxidant stack — popularized as harm-reduction adjunct for MDMA neuroprotection.

Key compound: acetyl-L-carnitineC9H17NO4 · 203.24 g/mol

What it is

Mitochondrial antioxidant stack — popularized as harm-reduction adjunct for MDMA neuroprotection.

Food sources

Dietary protein from animal sources (meat, fish, eggs, dairy) and plant sources (soy, legumes, grains)Free-form amino acid powders and capsulesTargeted pre-workout, recovery, or sleep formulations

Goals

Pre-Drug Use SupportPost-Drug Use RecoveryHealthy Aging

How it works

ALCAR supports mitochondrial β-oxidation; ALA is a universal antioxidant and recycles vit C/E and glutathione.

Pathways

  • Mitochondrial energetics
  • Antioxidant recycling

Effects

  • +Animal evidence for reduced serotonergic neurotoxicity from MDMA supports

What the research supports

Animal evidence for reduced serotonergic neurotoxicity from MDMAlimited

Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.

Typical dose
ALCAR 500–1000 mg + ALA 300–600 mg before and 4–6h after; avoid late-night ALCAR
TimingConsistent daily timing recommended; split larger doses if GI tolerance is a concern.
With foodWith food
Best formMost evidence is based on the free-form crystalline powder form.
Shop ALCAR + ALA (Mitochondrial Protection) on Amazon ↗

As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.

Side effects & interactions

Common side effects

  • Insomnia (ALCAR if late)

Medication interactions

Prescription medications (general)minor

Always disclose ALCAR + ALA (Mitochondrial Protection) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.

Check any supplement–medication combination with your pharmacist before starting.

Combines with

Pairs well

  • NAD+ precursor (NMN or NR)Complementary mitochondrial and sirtuin support.
  • Omega-3Lowers inflammation and supports membrane integrity.

Common forms

  • Free-form crystalline powder
  • Capsules or tablets
  • Pre-mixed recovery or hydration beverages
  • Time-release formulations

Key studies

8 studies cited in total.

PubMed: ALCAR + ALA (Mitochondrial Protection) — Animal evidence for reduced serotonergic neurotoxicity from MDMA ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching ALCAR + ALA (Mitochondrial Protection) and "Animal evidence for reduced serotonergic neurotoxicity from MDMA". Filter by RCT, meta-analysis, or year on the results page.

PubMed: ALCAR + ALA (Mitochondrial Protection) — randomized controlled trial ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching ALCAR + ALA (Mitochondrial Protection) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

PubMed: ALCAR + ALA (Mitochondrial Protection) — meta-analysis ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching ALCAR + ALA (Mitochondrial Protection) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

Discussion

Loading discussion…